HomeSLNO • NASDAQ
add
Soleno Therapeutics Inc
Previous close
$48.82
Day range
$45.09 - $49.80
Year range
$36.61 - $59.75
Market cap
1.97B USD
Avg Volume
412.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 58.79M | 358.25% |
Net income | -55.98M | -395.59% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -58.29M | -372.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 291.44M | 71.76% |
Total assets | 330.97M | 83.17% |
Total liabilities | 85.86M | 270.34% |
Total equity | 245.11M | — |
Shares outstanding | 45.70M | — |
Price to book | 9.11 | — |
Return on assets | -46.83% | — |
Return on capital | -51.96% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -55.98M | -395.59% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1999
Headquarters
Website
Employees
33
